During the second quarter, we continued to execute on our commercial strategies and benefit from our investments, even as we saw some patients and surgeons prioritizing travel and time away from their practices.

Aug 8, 2023 / CEO / receipt, needs a key / John Treese, CEO | earnings call 2023-08-08 | transcript 5d551dbe-a700-4eae-9ad6-b0cadcbd7698 | chars 4648-4859 | segment 4